3.64
Newcelx Ltd Borsa (NCEL) Ultime notizie
NewcelX Ltd. (NCEL) -8.5% in After-hours: Decline Amid Routine Trading Conditions - Stocks Telegraph
NLSP SEC FilingsNls Pharmaceutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board (PR Newswire) - Aktiellt
NewcelX Ltd.Ordinary Shares (NQ: NCEL - Markets Financial Content
NewCelX Appoints EY as New Auditor Following Merger - MSN
[6-K] NLS Pharmaceutics Ltd. Current Report (Foreign Issuer) | NLSP SEC FilingForm 6-K - Stock Titan
NewcelX appoints ALS specialist to scientific advisory board By Investing.com - Investing.com Nigeria
NewcelX appoints ALS specialist to scientific advisory board - Investing.com
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - Finviz
NewcelX Appoints Renowned Neurologist to Strengthen Scientific Advisory Board - TipRanks
Price to sales ratio of NewcelX Ltd. – NASDAQ:NCEL - TradingView
Press Release: NewcelX Announces Scientific Leadership With the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - 富途牛牛
NewcelX Ltd. (NCEL) - Zacks Investment Research
NLS Pharmaceutics to execute 1-for-10 reverse share split - MSN
NewcelX Ltd. (NCEL) company profile and facts - Yahoo Finance UK
NewcelX Announces New CFO Appointment Following Merger - MSN
NewcelX Ltd. (NCEL) interactive stock chart - Yahoo Finance UK
NewcelX Ltd. (NCEL) Stock Forum & Discussion - Yahoo! Finance Canada
NewcelX Ltd (NCEL) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
NewcelX Ltd (NCEL) Stock Earnings Transcripts - GuruFocus
NewcelX appoints Omri Hagai as chief financial officer, effective December 10 By Investing.com - Investing.com Australia
NewcelX appoints Omri Hagai as chief financial officer, effective December 10 - Investing.com India
Neurology expert Prof. Ben-Hur joins NewcelX scientific board By Investing.com - Investing.com Nigeria
NewcelX Ltd. Revenue Breakdown – NASDAQ:NCEL - TradingView
NLS Pharmaceutics Announces Reverse Share Split and Name Change Amid Merger - MSN
NewcelX Ltd. (NCEL) analyst ratings, estimates and forecasts - Yahoo Finance Australia
NewcelX Ltd. (NCEL) Income Statement - Yahoo! Finance Canada
NewcelX Ltd. (NCEL) valuation measures and financial statistics - Yahoo Finance Australia
NCEL Interactive Stock Chart | NewcelX Ltd. Stock - Yahoo Finance
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - WV News
Neurology expert Prof. Ben-Hur joins NewcelX scientific board - Investing.com
NewcelX Ltd. (NCEL) Stock Major Holders - Yahoo! Finance Canada
NewcelX Ltd. (NCEL) Latest Stock News & Headlines - Yahoo! Finance Canada
NCEL Financial Statements & ChartsNewcelx Ltd MacroTrends - CMLviz
NCEL Pivot Points, Technical Analysis and Moving AveragesNewcelx Ltd Technicals - CMLviz
NewcelX outlines clinical development roadmap for neurodegenerative therapies By Investing.com - Investing.com Nigeria
NewcelX outlines clinical development roadmap for neurodegenerative therapies - Investing.com India
NewcelX Ltd. (NCEL) stock price, news, quote and history - Yahoo Finance UK
NCEL News Today | Why did NLS Pharmaceutics stock go up today? - MarketBeat
NewcelX Ltd. (NCEL) Stock Price, News, Quote & History - Yahoo! Finance Canada
NewcelX Ltd. (KDST.TA) Stock Price, News, Quote & History - Yahoo! Finance Canada
NLS Pharmaceutics (NCEL) Stock Price, News & Analysis - MarketBeat
NewcelX Ltd. (NCEL) Options Chain - Yahoo! Finance Canada
NewcelX Ltd. (NCEL) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share Price of $3.10, Representing 48% Above the Market S - MarketScreener
NewcelX Unveils Strategic Initiatives and Clinical Advancements - TipRanks
NewceIX CEO issues letter to shareholders - MarketScreener
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):